Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT00127374 Withdrawn - Obesity Clinical Trials

Mood and Behavior Changes Among Overweight Adolescent Females

Start date: January 2005
Phase: N/A
Study type: Observational

The specific aims of this study are to document the co-existence of depression, low self-esteem, and high-risk behaviors among overweight and at-risk for overweight female adolescents; and decrease the prevalence of high-risk behaviors by improving depressive symptoms/signs and self-esteem through weight management intervention strategies that encourage long-term mental and physical well being. The proposed research will test the following hypotheses: - Overweight and at-risk for overweight female adolescents have poor self-esteem that may mask depression and mediate high-risk behaviors; and - Improved weight perception decreases participation in high-risk behavior secondary to improved self-esteem and depression.

NCT ID: NCT00119028 Withdrawn - Clinical trials for Post-Traumatic Stress Disorder

Expanding and Testing VA Collaborative Care Models for Depression

ReTIDES
Start date: April 2005
Phase: N/A
Study type: Interventional

Based on the published evidence, collaborative care for depression is both necessary and sufficient for improving care and outcomes for depressed patients in primary care settings. The Translating Initiatives in Depression into Effective Solutions (TIDES) project, upon which ReTIDES is based, developed a VA-adapted version of collaborative care through input from veterans, clinicians, and managers. The initial TIDES project resulted in a clinically stable and effective model as tested in seven primary care practices in three VISNs. This positive result provided the basis for spreading and sustaining the TIDES model and initiating the study of national implementation strategies and issues.

NCT ID: NCT00108316 Withdrawn - Depression Clinical Trials

Determinants in Antidepressant Outcomes

Start date: January 2004
Phase: N/A
Study type: Interventional

This study is designed to understand if a biological measurement, of how platelets respond to serotonin (a chemical in the blood sometimes referred to as SERT), can provide information that will determine an "ideal dose," one specifically tailored for each individual's chemistry. The biological measurement will be obtained by testing a blood sample. There will be approximately 120 control subjects expected for enrollment.